Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine – Physician Perspective

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Telemedicine, the use of electronic communication for the delivery of remote clinical care, has been recognized as a critical strategy during the ongoing COVID-19 pandemic to limit the risk of person-to-person transmission of the virus as social distancing became the norm. In this report, the countries covered includes the US, Japan, the 4EU (France, Italy, Germany, and Spain), and the UK.

It was widely anticipated that COVID-19 was the tipping point for telemedicine as the full potential of the technology was increasingly realized by patients, healthcare systems, and payers. As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. Nevertheless, after an unprecedented rise during the first few months of pandemic, the use of telemedicine has stabilized; nevertheless, it has not reached its peak.

In recent years, healthcare reforms and legislation have sped up the implementation of telemedicine technology. However, over 50% of respondents from Japan reported their use of telemedicine had remained unchanged because of the COVID-19 pandemic, whereas in the US and EU, over 75% of respondents increased their use of the technology. Despite the Japanese government easing telemedicine-related restrictions, resistance to change from physicians and medical societies remains among the top barriers preventing higher uptake.

Furthermore, the lack of awareness due to limited information shared by insurance providers, insufficient knowledge, and a low understanding of the telemedicine concept remain as the main hindrances to patients embracing telemedicine.

How COVID-19 accelerated the use of remote monitoring technologies?

Telemedicine is found to be beneficial for patients, HCPs, and healthcare systems. As the future of healthcare requires a shift from treatments to prevention, remote monitoring technologies were uniquely positioned to become the flag-bearer of this trend. Therefore, telemedicine was being pushed into the spotlight by COVID-19. When paired together with remote monitoring tools, telemedicine enabled the healthcare providers to get data-driven insights into patient conditions and eventually helped to deliver patient-centric treatments and disease management approaches. The continued adoption of telemedicine was also supported by continuous technological advancement with telemedicine becoming a standard patient management option in the clinical workflow.

Regional impact of telemedicine in COVID-19

Regional impact of telemedicine in COVID-19

For more insights, download a free report sample

How telemedicine evolved during COVID-19?

Telemedicine trend was accelerated by the onset of COVID-19. While delivery of healthcare has historically been viewed as an in-person experience, COVID-19 has turned the perception of patient care 180 degrees with telemedicine becoming standard in clinical workflows. Use of telemedicine had surged as a result of the COVID-19 pandemic, with healthcare providers, payers, and telemedicine companies all reporting increased demand for telemedicine services. The government also acted swiftly to expand telemedicine availability as well.

The US regulations governing the use of telemedicine had changed significantly during COVID-19, rapidly expanding access to these services and leading to an unprecedented surge in demand. In Europe, several countries had also introduced temporary changes to reimbursement policies for telemedicine as a result of the pandemic.

While evolving digitalization of healthcare sectors in Europe and the US allowed these regions to transition to telehealth services relatively easily during the pandemic, the COVID-19 pandemic has brought significant changes in the treatment of patients across all markets. Thus, the use of telemedicine is expected to remain much higher compared to pre-COVID-19 levels in many countries worldwide.

What are the key players in the telemedicine field?

The companies involved in telemedicine include Teladoc Health, Amwel, Epic Systems Corporation, SecureVideo, Medici, MDLive, InTouch Health, OnCall Health, and SBR Health.

Telemedicine market, by key players

Telemedicine market, by key players

For more insights, download a free report sample

Market report scope

Key Players Teladoc Health, Amwel, Epic Systems Corporation, SecureVideo, Medici, MDLive, InTouch Health, OnCall Health and SBR Health
Countries Covered The US, Japan, France, Italy, Germany, and Spain, the UK


This report provides a comprehensive analysis of the Coronavirus Disease 2019 (COVID-19) Impact on


  • This report combines information obtained from secondary sources and primary research with healthcare industry professionals, key opinion leaders (KOLs), and physicians from different therapy areas (pediatrics, pulmonology, primary case, dermatology, internal medicine, endocrinology, cardiology, and infectious disease). The interviews and surveys with physicians and KOLs were conducted between 2020-2021. Components of the report include:
  • Telemedicine Overview – an overview of telemedicine, including benefits and barriers.
  • Telemedicine Sector in the US, Europe, and Japan Before COVID-19 – A review of the telemedicine sector in the US, Europe, and Japan before the pandemic, including online survey and poll data.
  • Telemedicine Sector in the US, Europe, and Japan During COVID-19 – A review of the telemedicine sector growth in the US, Europe, and Japan during the pandemic, including online survey and poll data.
  • Telemedicine Sector in the US, Europe, and Japan after COVID-19 – A review of the telemedicine sector post COVID-19, including online survey and poll data.

Reasons to Buy

  • Get an overview on how telemedicine is being used today and how the technology is expected to affect the healthcare sector in the future.
  • Explore the changing telemedicine regulatory landscapes in the US, Europe, and Japan.
  • See how physician use of telemedicine has changed in these regions as a result of the pandemic.
  • Explore how physician use of telemedicine is expected to change in the future in these regions.

Table of Contents

1 Table of Contents (PowerPoint Deck)

1.1 Study Design

1.1.1 Survey Respondent Mix

1.1.2 Objectives and Design

1.1.3 Survey Respondent Profiles

1.2 Key Findings

1.3 Telemedicine Overview

1.3.1 What Is Telemedicine?

1.3.2 COVID-19 Accelerated the Use of Remote Monitoring Technologies

1.3.3 What Are the Different Types of Telemedicine?

1.3.4 What Are the Benefits of Telemedicine?

1.3.5 What Are the Common Barriers to Telemedicine?

1.3.6 Companies Playing an Active Role in the Telemedicine Field

1.4 Telemedicine Sector in the US, Europe, and Japan Before COVID-19

1.4.1 In the US, Pre-Pandemic Use of Telemedicine Was Rising but Remained Low Overall

1.4.2 In Europe, the UK was among the Most Established Markets for Telemedicine Before COVID-19

1.4.3 Use of Telemedicine Was Still at the Infancy Stage in Japan

1.4.4 Telemedicine Sector Before COVID-19 – Survey Data

1.4.5 Telemedicine Sector Before COVID-19 – Survey Data by Region

1.4.6 Telemedicine Use Before COVID-19 – Physicians Perspective

1.5 Telemedicine Sector in the US, Europe, and Japan During COVID-19

1.5.1 Social Distancing and Lockdown Measures Have Led to a Surge in Telemedicine Use

1.5.2 The Regulatory Landscape for Telemedicine in the US Has Changed Significantly as a Result of the Pandemic

1.5.3 Changes to Reimbursement Policies in Some European Countries Have Led to a Surge in Demand for Telemedicine

1.5.4 Japan Has Introduced New Measures to Ease Telemedicine Restrictions

1.5.5 Telemedicine Sector During COVID-19 – Survey Data

1.5.6 Telemedicine Sector During COVID-19 – Survey Data by Region

1.5.7 Increased Website Traffic for Leading Provider Telemedicine Platforms from March 2020

1.5.8 Job Analytics – Telemedicine-Related Job Growth in the US

1.5.9 Use of Telemedicine in Clinical Trials

1.5.10 Telemedicine Use During COVID-19 – Physicians Perspective

1.6 Telemedicine Sector Post-COVID-19

1.6.1 Telemedicine – Industry Trends Accelerated the Most by COVID-19

1.6.2 The Future of Telemedicine Post-COVID-19

1.6.3 Telemedicine Sector Post-COVID-19 – Survey Data

1.6.4 Telemedicine to Reach its Peak

1.6.5 Telemedicine Use After COVID-19 – Physicians Perspective

1.7 Summary of Key Findings

1.8 Appendix

1.9 Contact Us

Frequently asked questions

Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine – Physician Perspective thematic reports
Currency USD

Can be used by individual purchaser only


Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine – Physician Perspective was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
5-Hydroxytryptamine Receptor 2A - Drugs In Development, 2024
$3,500 | June 2024
Mu Type Opioid Receptor - Drugs In Development, 2024
$3,500 | June 2024
GTPase KRas - Drugs In Development, 2024
$3,500 | June 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine – Physician Perspective in real time.

  • Access a live Coronavirus Disease 2019 (COVID-19) Impact on Telemedicine – Physician Perspective dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.